Table of Content

1 Leukotriene Inhibitors Market Overview
1.1 Leukotriene Inhibitors Product Overview
1.2 Leukotriene Inhibitors Market Segment by Type
1.2.1 Montelukast
1.2.2 Zafirlukast
1.2.3 Proust
1.2.4 Other
1.3 Global Leukotriene Inhibitors Market Size by Type
1.3.1 Global Leukotriene Inhibitors Market Size Overview by Type (2018-2029)
1.3.2 Global Leukotriene Inhibitors Historic Market Size Review by Type (2018-2024)
1.3.3 Global Leukotriene Inhibitors Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Leukotriene Inhibitors Sales Breakdown by Type (2018-2024)
1.4.2 Europe Leukotriene Inhibitors Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Leukotriene Inhibitors Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Leukotriene Inhibitors Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Leukotriene Inhibitors Sales Breakdown by Type (2018-2024)
2 Global Leukotriene Inhibitors Market Competition by Company
2.1 Global Top Players by Leukotriene Inhibitors Sales (2018-2024)
2.2 Global Top Players by Leukotriene Inhibitors Revenue (2018-2024)
2.3 Global Top Players by Leukotriene Inhibitors Price (2018-2024)
2.4 Global Top Manufacturers Leukotriene Inhibitors Manufacturing Base Distribution, Sales Area, Product Type
2.5 Leukotriene Inhibitors Market Competitive Situation and Trends
2.5.1 Leukotriene Inhibitors Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Leukotriene Inhibitors Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Leukotriene Inhibitors as of 2022)
2.7 Date of Key Manufacturers Enter into Leukotriene Inhibitors Market
2.8 Key Manufacturers Leukotriene Inhibitors Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Leukotriene Inhibitors Status and Outlook by Region
3.1 Global Leukotriene Inhibitors Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Leukotriene Inhibitors Historic Market Size by Region
3.2.1 Global Leukotriene Inhibitors Sales in Volume by Region (2018-2024)
3.2.2 Global Leukotriene Inhibitors Sales in Value by Region (2018-2024)
3.2.3 Global Leukotriene Inhibitors Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Leukotriene Inhibitors Forecasted Market Size by Region
3.3.1 Global Leukotriene Inhibitors Sales in Volume by Region (2024-2029)
3.3.2 Global Leukotriene Inhibitors Sales in Value by Region (2024-2029)
3.3.3 Global Leukotriene Inhibitors Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Leukotriene Inhibitors by Application
4.1 Leukotriene Inhibitors Market Segment by Application
4.1.1 Asthma
4.1.2 COPD
4.1.3 Allergic Rhinitis
4.1.4 Other
4.2 Global Leukotriene Inhibitors Market Size by Application
4.2.1 Global Leukotriene Inhibitors Market Size Overview by Application (2018-2029)
4.2.2 Global Leukotriene Inhibitors Historic Market Size Review by Application (2018-2024)
4.2.3 Global Leukotriene Inhibitors Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Leukotriene Inhibitors Sales Breakdown by Application (2018-2024)
4.3.2 Europe Leukotriene Inhibitors Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Leukotriene Inhibitors Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Leukotriene Inhibitors Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Leukotriene Inhibitors Sales Breakdown by Application (2018-2024)
5 North America Leukotriene Inhibitors by Country
5.1 North America Leukotriene Inhibitors Historic Market Size by Country
5.1.1 North America Leukotriene Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Leukotriene Inhibitors Sales in Volume by Country (2018-2024)
5.1.3 North America Leukotriene Inhibitors Sales in Value by Country (2018-2024)
5.2 North America Leukotriene Inhibitors Forecasted Market Size by Country
5.2.1 North America Leukotriene Inhibitors Sales in Volume by Country (2024-2029)
5.2.2 North America Leukotriene Inhibitors Sales in Value by Country (2024-2029)
6 Europe Leukotriene Inhibitors by Country
6.1 Europe Leukotriene Inhibitors Historic Market Size by Country
6.1.1 Europe Leukotriene Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Leukotriene Inhibitors Sales in Volume by Country (2018-2024)
6.1.3 Europe Leukotriene Inhibitors Sales in Value by Country (2018-2024)
6.2 Europe Leukotriene Inhibitors Forecasted Market Size by Country
6.2.1 Europe Leukotriene Inhibitors Sales in Volume by Country (2024-2029)
6.2.2 Europe Leukotriene Inhibitors Sales in Value by Country (2024-2029)
7 Asia-Pacific Leukotriene Inhibitors by Region
7.1 Asia-Pacific Leukotriene Inhibitors Historic Market Size by Region
7.1.1 Asia-Pacific Leukotriene Inhibitors Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Leukotriene Inhibitors Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Leukotriene Inhibitors Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Leukotriene Inhibitors Forecasted Market Size by Region
7.2.1 Asia-Pacific Leukotriene Inhibitors Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Leukotriene Inhibitors Sales in Value by Region (2024-2029)
8 Latin America Leukotriene Inhibitors by Country
8.1 Latin America Leukotriene Inhibitors Historic Market Size by Country
8.1.1 Latin America Leukotriene Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Leukotriene Inhibitors Sales in Volume by Country (2018-2024)
8.1.3 Latin America Leukotriene Inhibitors Sales in Value by Country (2018-2024)
8.2 Latin America Leukotriene Inhibitors Forecasted Market Size by Country
8.2.1 Latin America Leukotriene Inhibitors Sales in Volume by Country (2024-2029)
8.2.2 Latin America Leukotriene Inhibitors Sales in Value by Country (2024-2029)
9 Middle East and Africa Leukotriene Inhibitors by Country
9.1 Middle East and Africa Leukotriene Inhibitors Historic Market Size by Country
9.1.1 Middle East and Africa Leukotriene Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Leukotriene Inhibitors Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Leukotriene Inhibitors Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Leukotriene Inhibitors Forecasted Market Size by Country
9.2.1 Middle East and Africa Leukotriene Inhibitors Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Leukotriene Inhibitors Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Mallinckrodt plc
10.1.1 Mallinckrodt plc Company Information
10.1.2 Mallinckrodt plc Introduction and Business Overview
10.1.3 Mallinckrodt plc Leukotriene Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Mallinckrodt plc Leukotriene Inhibitors Products Offered
10.1.5 Mallinckrodt plc Recent Development
10.2 Sun Pharmaceutical Industries Ltd
10.2.1 Sun Pharmaceutical Industries Ltd Company Information
10.2.2 Sun Pharmaceutical Industries Ltd Introduction and Business Overview
10.2.3 Sun Pharmaceutical Industries Ltd Leukotriene Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Sun Pharmaceutical Industries Ltd Leukotriene Inhibitors Products Offered
10.2.5 Sun Pharmaceutical Industries Ltd Recent Development
10.3 Novartis AG
10.3.1 Novartis AG Company Information
10.3.2 Novartis AG Introduction and Business Overview
10.3.3 Novartis AG Leukotriene Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Novartis AG Leukotriene Inhibitors Products Offered
10.3.5 Novartis AG Recent Development
10.4 Endo Pharmaceuticals plc
10.4.1 Endo Pharmaceuticals plc Company Information
10.4.2 Endo Pharmaceuticals plc Introduction and Business Overview
10.4.3 Endo Pharmaceuticals plc Leukotriene Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Endo Pharmaceuticals plc Leukotriene Inhibitors Products Offered
10.4.5 Endo Pharmaceuticals plc Recent Development
10.5 Zydus Cadila
10.5.1 Zydus Cadila Company Information
10.5.2 Zydus Cadila Introduction and Business Overview
10.5.3 Zydus Cadila Leukotriene Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Zydus Cadila Leukotriene Inhibitors Products Offered
10.5.5 Zydus Cadila Recent Development
10.6 Mylan NV
10.6.1 Mylan NV Company Information
10.6.2 Mylan NV Introduction and Business Overview
10.6.3 Mylan NV Leukotriene Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Mylan NV Leukotriene Inhibitors Products Offered
10.6.5 Mylan NV Recent Development
10.7 Mayne Pharma Group Limited
10.7.1 Mayne Pharma Group Limited Company Information
10.7.2 Mayne Pharma Group Limited Introduction and Business Overview
10.7.3 Mayne Pharma Group Limited Leukotriene Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Mayne Pharma Group Limited Leukotriene Inhibitors Products Offered
10.7.5 Mayne Pharma Group Limited Recent Development
10.8 Teva Pharmaceutical Industries Ltd
10.8.1 Teva Pharmaceutical Industries Ltd Company Information
10.8.2 Teva Pharmaceutical Industries Ltd Introduction and Business Overview
10.8.3 Teva Pharmaceutical Industries Ltd Leukotriene Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Teva Pharmaceutical Industries Ltd Leukotriene Inhibitors Products Offered
10.8.5 Teva Pharmaceutical Industries Ltd Recent Development
10.9 Amneal Pharmaceutical Inc
10.9.1 Amneal Pharmaceutical Inc Company Information
10.9.2 Amneal Pharmaceutical Inc Introduction and Business Overview
10.9.3 Amneal Pharmaceutical Inc Leukotriene Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Amneal Pharmaceutical Inc Leukotriene Inhibitors Products Offered
10.9.5 Amneal Pharmaceutical Inc Recent Development
10.10 Avet Pharmaceuticals Inc
10.10.1 Avet Pharmaceuticals Inc Company Information
10.10.2 Avet Pharmaceuticals Inc Introduction and Business Overview
10.10.3 Avet Pharmaceuticals Inc Leukotriene Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Avet Pharmaceuticals Inc Leukotriene Inhibitors Products Offered
10.10.5 Avet Pharmaceuticals Inc Recent Development
10.11 Aurobindo Pharma
10.11.1 Aurobindo Pharma Company Information
10.11.2 Aurobindo Pharma Introduction and Business Overview
10.11.3 Aurobindo Pharma Leukotriene Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Aurobindo Pharma Leukotriene Inhibitors Products Offered
10.11.5 Aurobindo Pharma Recent Development
10.12 GSK plc
10.12.1 GSK plc Company Information
10.12.2 GSK plc Introduction and Business Overview
10.12.3 GSK plc Leukotriene Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.12.4 GSK plc Leukotriene Inhibitors Products Offered
10.12.5 GSK plc Recent Development
10.13 Almirall, SA
10.13.1 Almirall, SA Company Information
10.13.2 Almirall, SA Introduction and Business Overview
10.13.3 Almirall, SA Leukotriene Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Almirall, SA Leukotriene Inhibitors Products Offered
10.13.5 Almirall, SA Recent Development
10.14 Merck & Co., Inc
10.14.1 Merck & Co., Inc Company Information
10.14.2 Merck & Co., Inc Introduction and Business Overview
10.14.3 Merck & Co., Inc Leukotriene Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Merck & Co., Inc Leukotriene Inhibitors Products Offered
10.14.5 Merck & Co., Inc Recent Development
10.15 Bausch Health
10.15.1 Bausch Health Company Information
10.15.2 Bausch Health Introduction and Business Overview
10.15.3 Bausch Health Leukotriene Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Bausch Health Leukotriene Inhibitors Products Offered
10.15.5 Bausch Health Recent Development
10.16 Sandoz International GmbH
10.16.1 Sandoz International GmbH Company Information
10.16.2 Sandoz International GmbH Introduction and Business Overview
10.16.3 Sandoz International GmbH Leukotriene Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Sandoz International GmbH Leukotriene Inhibitors Products Offered
10.16.5 Sandoz International GmbH Recent Development
10.17 Circassia Pharmaceuticals
10.17.1 Circassia Pharmaceuticals Company Information
10.17.2 Circassia Pharmaceuticals Introduction and Business Overview
10.17.3 Circassia Pharmaceuticals Leukotriene Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.17.4 Circassia Pharmaceuticals Leukotriene Inhibitors Products Offered
10.17.5 Circassia Pharmaceuticals Recent Development
10.18 AstraZeneca
10.18.1 AstraZeneca Company Information
10.18.2 AstraZeneca Introduction and Business Overview
10.18.3 AstraZeneca Leukotriene Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.18.4 AstraZeneca Leukotriene Inhibitors Products Offered
10.18.5 AstraZeneca Recent Development
10.19 Sanofi
10.19.1 Sanofi Company Information
10.19.2 Sanofi Introduction and Business Overview
10.19.3 Sanofi Leukotriene Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.19.4 Sanofi Leukotriene Inhibitors Products Offered
10.19.5 Sanofi Recent Development
10.20 McKesson Corporation
10.20.1 McKesson Corporation Company Information
10.20.2 McKesson Corporation Introduction and Business Overview
10.20.3 McKesson Corporation Leukotriene Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.20.4 McKesson Corporation Leukotriene Inhibitors Products Offered
10.20.5 McKesson Corporation Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Leukotriene Inhibitors Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Leukotriene Inhibitors Industrial Chain Analysis
11.4 Leukotriene Inhibitors Market Dynamics
11.4.1 Leukotriene Inhibitors Industry Trends
11.4.2 Leukotriene Inhibitors Market Drivers
11.4.3 Leukotriene Inhibitors Market Challenges
11.4.4 Leukotriene Inhibitors Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Leukotriene Inhibitors Distributors
12.3 Leukotriene Inhibitors Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Montelukast
Table 2. Major Company of Zafirlukast
Table 3. Major Company of Proust
Table 4. Major Company of Other
Table 5. Global Leukotriene Inhibitors Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Leukotriene Inhibitors Sales by Type (2018-2024) & (K Units)
Table 7. Global Leukotriene Inhibitors Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Leukotriene Inhibitors Sales by Type (2018-2024) & (US& Million)
Table 9. Global Leukotriene Inhibitors Market Share in Value by Type (2018-2024)
Table 10. Global Leukotriene Inhibitors Price by Type (2018-2024) & (US$/Unit)
Table 11. Global Leukotriene Inhibitors Sales by Type (2024-2029) & (K Units)
Table 12. Global Leukotriene Inhibitors Sales Market Share in Volume by Type (2024-2029)
Table 13. Global Leukotriene Inhibitors Sales by Type (2024-2029) & (US$ Million)
Table 14. Global Leukotriene Inhibitors Sales Market Share in Value by Type (2024-2029)
Table 15. Global Leukotriene Inhibitors Price by Type (2024-2029) & (US$/Unit)
Table 16. North America Leukotriene Inhibitors Sales by Type (2018-2024) & (K Units)
Table 17. North America Leukotriene Inhibitors Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Leukotriene Inhibitors Sales (K Units) by Type (2018-2024)
Table 19. Europe Leukotriene Inhibitors Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Leukotriene Inhibitors Sales (K Units) by Type (2018-2024)
Table 21. Asia-Pacific Leukotriene Inhibitors Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Leukotriene Inhibitors Sales (K Units) by Type (2018-2024)
Table 23. Latin America Leukotriene Inhibitors Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Leukotriene Inhibitors Sales (K Units) by Type (2018-2024)
Table 25. Middle East and Africa Leukotriene Inhibitors Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Leukotriene Inhibitors Sales by Company (2018-2024) & (K Units)
Table 27. Global Leukotriene Inhibitors Sales Share by Company (2018-2024)
Table 28. Global Leukotriene Inhibitors Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Leukotriene Inhibitors Revenue Share by Company (2018-2024)
Table 30. Global Market Leukotriene Inhibitors Price by Company (2018-2024) & (US$/Unit)
Table 31. Global Leukotriene Inhibitors Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Leukotriene Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Leukotriene Inhibitors as of 2022)
Table 34. Date of Key Manufacturers Enter into Leukotriene Inhibitors Market
Table 35. Key Manufacturers Leukotriene Inhibitors Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Leukotriene Inhibitors Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Global Leukotriene Inhibitors Sales by Region (2018-2024) & (K Units)
Table 39. Global Leukotriene Inhibitors Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Leukotriene Inhibitors Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Leukotriene Inhibitors Sales Market Share in Value by Region (2018-2024)
Table 42. Global Leukotriene Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 43. Global Leukotriene Inhibitors Sales by Region (2024-2029) & (K Units)
Table 44. Global Leukotriene Inhibitors Sales Market Share in Volume by Region (2024-2029)
Table 45. Global Leukotriene Inhibitors Sales by Region (2024-2029) & (US$ Million)
Table 46. Global Leukotriene Inhibitors Sales Market Share in Value by Region (2024-2029)
Table 47. Global Leukotriene Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 48. Global Leukotriene Inhibitors Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 49. Global Leukotriene Inhibitors Sales by Application (2018-2024) & (K Units)
Table 50. Global Leukotriene Inhibitors Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Leukotriene Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Leukotriene Inhibitors Sales Market Share in Value by Application (2018-2024)
Table 53. Global Leukotriene Inhibitors Price by Application (2018-2024) & (US$/Unit)
Table 54. Global Leukotriene Inhibitors Sales by Application (2024-2029) & (K Units)
Table 55. Global Leukotriene Inhibitors Sales Market Share in Volume by Application (2024-2029)
Table 56. Global Leukotriene Inhibitors Sales by Application (2024-2029) & (US$ Million)
Table 57. Global Leukotriene Inhibitors Sales Market Share in Value by Application (2024-2029)
Table 58. Global Leukotriene Inhibitors Price by Application (2024-2029) & (US$/Unit)
Table 59. North America Leukotriene Inhibitors Sales by Application (2018-2024) (K Units)
Table 60. North America Leukotriene Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Leukotriene Inhibitors Sales by Application (2018-2024) (K Units)
Table 62. Europe Leukotriene Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Leukotriene Inhibitors Sales by Application (2018-2024) (K Units)
Table 64. Asia-Pacific Leukotriene Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Leukotriene Inhibitors Sales by Application (2018-2024) (K Units)
Table 66. Latin America Leukotriene Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Leukotriene Inhibitors Sales by Application (2018-2024) (K Units)
Table 68. Middle East and Africa Leukotriene Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Leukotriene Inhibitors Sales by Country (2018-2024) & (K Units)
Table 70. North America Leukotriene Inhibitors Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Leukotriene Inhibitors Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Leukotriene Inhibitors Sales Market Share in Value by Country (2018-2024)
Table 73. North America Leukotriene Inhibitors Sales by Country (2024-2029) & (K Units)
Table 74. North America Leukotriene Inhibitors Sales Market Share in Volume by Country (2024-2029)
Table 75. North America Leukotriene Inhibitors Sales by Country (2024-2029) & (US$ Million)
Table 76. North America Leukotriene Inhibitors Sales Market Share in Value by Country (2024-2029)
Table 77. Europe Leukotriene Inhibitors Sales by Country (2018-2024) & (K Units)
Table 78. Europe Leukotriene Inhibitors Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Leukotriene Inhibitors Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Leukotriene Inhibitors Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Leukotriene Inhibitors Sales by Country (2024-2029) & (K Units)
Table 82. Europe Leukotriene Inhibitors Sales Market Share in Volume by Country (2024-2029)
Table 83. Europe Leukotriene Inhibitors Sales by Country (2024-2029) & (US$ Million)
Table 84. Europe Leukotriene Inhibitors Sales Market Share in Value by Country (2024-2029)
Table 85. Asia-Pacific Leukotriene Inhibitors Sales by Region (2018-2024) & (K Units)
Table 86. Asia-Pacific Leukotriene Inhibitors Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Leukotriene Inhibitors Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Leukotriene Inhibitors Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Leukotriene Inhibitors Sales by Region (2024-2029) & (K Units)
Table 90. Asia-Pacific Leukotriene Inhibitors Sales Market Share in Volume by Region (2024-2029)
Table 91. Asia-Pacific Leukotriene Inhibitors Sales by Region (2024-2029) & (US$ Million)
Table 92. Asia-Pacific Leukotriene Inhibitors Sales Market Share in Value by Region (2024-2029)
Table 93. Latin America Leukotriene Inhibitors Sales by Country (2018-2024) & (K Units)
Table 94. Latin America Leukotriene Inhibitors Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Leukotriene Inhibitors Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Leukotriene Inhibitors Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Leukotriene Inhibitors Sales by Country (2024-2029) & (K Units)
Table 98. Latin America Leukotriene Inhibitors Sales Market Share in Volume by Country (2024-2029)
Table 99. Latin America Leukotriene Inhibitors Sales by Country (2024-2029) & (US$ Million)
Table 100. Latin America Leukotriene Inhibitors Sales Market Share in Value by Country (2024-2029)
Table 101. Middle East and Africa Leukotriene Inhibitors Sales by Country (2018-2024) & (K Units)
Table 102. Middle East and Africa Leukotriene Inhibitors Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Leukotriene Inhibitors Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Leukotriene Inhibitors Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Leukotriene Inhibitors Sales by Country (2024-2029) & (K Units)
Table 106. Middle East and Africa Leukotriene Inhibitors Sales Market Share in Volume by Country (2024-2029)
Table 107. Middle East and Africa Leukotriene Inhibitors Sales by Country (2024-2029) & (US$ Million)
Table 108. Middle East and Africa Leukotriene Inhibitors Sales Market Share in Value by Country (2024-2029)
Table 109. Mallinckrodt plc Company Information
Table 110. Mallinckrodt plc Introduction and Business Overview
Table 111. Mallinckrodt plc Leukotriene Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 112. Mallinckrodt plc Leukotriene Inhibitors Product
Table 113. Mallinckrodt plc Recent Development
Table 114. Sun Pharmaceutical Industries Ltd Company Information
Table 115. Sun Pharmaceutical Industries Ltd Introduction and Business Overview
Table 116. Sun Pharmaceutical Industries Ltd Leukotriene Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 117. Sun Pharmaceutical Industries Ltd Leukotriene Inhibitors Product
Table 118. Sun Pharmaceutical Industries Ltd Recent Development
Table 119. Novartis AG Company Information
Table 120. Novartis AG Introduction and Business Overview
Table 121. Novartis AG Leukotriene Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 122. Novartis AG Leukotriene Inhibitors Product
Table 123. Novartis AG Recent Development
Table 124. Endo Pharmaceuticals plc Company Information
Table 125. Endo Pharmaceuticals plc Introduction and Business Overview
Table 126. Endo Pharmaceuticals plc Leukotriene Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 127. Endo Pharmaceuticals plc Leukotriene Inhibitors Product
Table 128. Endo Pharmaceuticals plc Recent Development
Table 129. Zydus Cadila Company Information
Table 130. Zydus Cadila Introduction and Business Overview
Table 131. Zydus Cadila Leukotriene Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 132. Zydus Cadila Leukotriene Inhibitors Product
Table 133. Zydus Cadila Recent Development
Table 134. Mylan NV Company Information
Table 135. Mylan NV Introduction and Business Overview
Table 136. Mylan NV Leukotriene Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 137. Mylan NV Leukotriene Inhibitors Product
Table 138. Mylan NV Recent Development
Table 139. Mayne Pharma Group Limited Company Information
Table 140. Mayne Pharma Group Limited Introduction and Business Overview
Table 141. Mayne Pharma Group Limited Leukotriene Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 142. Mayne Pharma Group Limited Leukotriene Inhibitors Product
Table 143. Mayne Pharma Group Limited Recent Development
Table 144. Teva Pharmaceutical Industries Ltd Company Information
Table 145. Teva Pharmaceutical Industries Ltd Introduction and Business Overview
Table 146. Teva Pharmaceutical Industries Ltd Leukotriene Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 147. Teva Pharmaceutical Industries Ltd Leukotriene Inhibitors Product
Table 148. Teva Pharmaceutical Industries Ltd Recent Development
Table 149. Amneal Pharmaceutical Inc Company Information
Table 150. Amneal Pharmaceutical Inc Introduction and Business Overview
Table 151. Amneal Pharmaceutical Inc Leukotriene Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 152. Amneal Pharmaceutical Inc Leukotriene Inhibitors Product
Table 153. Amneal Pharmaceutical Inc Recent Development
Table 154. Avet Pharmaceuticals Inc Company Information
Table 155. Avet Pharmaceuticals Inc Introduction and Business Overview
Table 156. Avet Pharmaceuticals Inc Leukotriene Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 157. Avet Pharmaceuticals Inc Leukotriene Inhibitors Product
Table 158. Avet Pharmaceuticals Inc Recent Development
Table 159. Aurobindo Pharma Company Information
Table 160. Aurobindo Pharma Introduction and Business Overview
Table 161. Aurobindo Pharma Leukotriene Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 162. Aurobindo Pharma Leukotriene Inhibitors Product
Table 163. Aurobindo Pharma Recent Development
Table 164. GSK plc Company Information
Table 165. GSK plc Introduction and Business Overview
Table 166. GSK plc Leukotriene Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 167. GSK plc Leukotriene Inhibitors Product
Table 168. GSK plc Recent Development
Table 169. Almirall, SA Company Information
Table 170. Almirall, SA Introduction and Business Overview
Table 171. Almirall, SA Leukotriene Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 172. Almirall, SA Leukotriene Inhibitors Product
Table 173. Almirall, SA Recent Development
Table 174. Merck & Co., Inc Company Information
Table 175. Merck & Co., Inc Introduction and Business Overview
Table 176. Merck & Co., Inc Leukotriene Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 177. Merck & Co., Inc Leukotriene Inhibitors Product
Table 178. Merck & Co., Inc Recent Development
Table 179. Bausch Health Company Information
Table 180. Bausch Health Introduction and Business Overview
Table 181. Bausch Health Leukotriene Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 182. Bausch Health Leukotriene Inhibitors Product
Table 183. Bausch Health Recent Development
Table 184. Sandoz International GmbH Company Information
Table 185. Sandoz International GmbH Introduction and Business Overview
Table 186. Sandoz International GmbH Leukotriene Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 187. Sandoz International GmbH Leukotriene Inhibitors Product
Table 188. Sandoz International GmbH Recent Development
Table 189. Circassia Pharmaceuticals Company Information
Table 190. Circassia Pharmaceuticals Introduction and Business Overview
Table 191. Circassia Pharmaceuticals Leukotriene Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 192. Circassia Pharmaceuticals Leukotriene Inhibitors Product
Table 193. Circassia Pharmaceuticals Recent Development
Table 194. AstraZeneca Company Information
Table 195. AstraZeneca Introduction and Business Overview
Table 196. AstraZeneca Leukotriene Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 197. AstraZeneca Leukotriene Inhibitors Product
Table 198. AstraZeneca Recent Development
Table 199. Sanofi Company Information
Table 200. Sanofi Introduction and Business Overview
Table 201. Sanofi Leukotriene Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 202. Sanofi Leukotriene Inhibitors Product
Table 203. Sanofi Recent Development
Table 204. McKesson Corporation Company Information
Table 205. McKesson Corporation Introduction and Business Overview
Table 206. McKesson Corporation Leukotriene Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 207. McKesson Corporation Leukotriene Inhibitors Product
Table 208. McKesson Corporation Recent Development
Table 209. Key Raw Materials Lists
Table 210. Raw Materials Key Suppliers Lists
Table 211. Leukotriene Inhibitors Market Trends
Table 212. Leukotriene Inhibitors Market Drivers
Table 213. Leukotriene Inhibitors Market Challenges
Table 214. Leukotriene Inhibitors Market Restraints
Table 215. Leukotriene Inhibitors Distributors List
Table 216. Leukotriene Inhibitors Downstream Customers
Table 217. Research Programs/Design for This Report
Table 218. Key Data Information from Secondary Sources
Table 219. Key Data Information from Primary Sources
List of Figures
Figure 1. Leukotriene Inhibitors Product Picture
Figure 2. Global Leukotriene Inhibitors Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Leukotriene Inhibitors Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Leukotriene Inhibitors Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Montelukast
Figure 6. Global Montelukast Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Zafirlukast
Figure 8. Global Zafirlukast Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of Proust
Figure 10. Global Proust Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Product Picture of Other
Figure 12. Global Other Sales YoY Growth (2018-2029) & (K Units)
Figure 13. Global Leukotriene Inhibitors Sales by Type (2018-2029) & (US$ Million)
Figure 14. Global Leukotriene Inhibitors Sales Market Share by Type in 2022 & 2029
Figure 15. North America Leukotriene Inhibitors Sales Market Share in Volume by Type in 2022
Figure 16. North America Leukotriene Inhibitors Sales Market Share in Value by Type in 2022
Figure 17. Europe Leukotriene Inhibitors Sales Market Share in Volume by Type in 2022
Figure 18. Europe Leukotriene Inhibitors Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Leukotriene Inhibitors Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Leukotriene Inhibitors Sales Market Share in Value by Type in 2022
Figure 21. Latin America Leukotriene Inhibitors Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Leukotriene Inhibitors Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Leukotriene Inhibitors Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Leukotriene Inhibitors Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Leukotriene Inhibitors Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Leukotriene Inhibitors Revenue in 2022
Figure 27. Leukotriene Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Asthma
Figure 29. Global Asthma Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of COPD
Figure 31. Global COPD Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Product Picture of Allergic Rhinitis
Figure 33. Global Allergic Rhinitis Sales YoY Growth (2018-2029) & (K Units)
Figure 34. Product Picture of Other
Figure 35. Global Other Sales YoY Growth (2018-2029) & (K Units)
Figure 36. Global Leukotriene Inhibitors Sales by Application (2018-2029) & (US$ Million)
Figure 37. Global Leukotriene Inhibitors Sales Market Share by Application in 2022 & 2029
Figure 38. North America Leukotriene Inhibitors Sales Market Share in Volume by Application in 2022
Figure 39. North America Leukotriene Inhibitors Sales Market Share in Value by Application in 2022
Figure 40. Europe Leukotriene Inhibitors Sales Market Share in Volume by Application in 2022
Figure 41. Europe Leukotriene Inhibitors Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Leukotriene Inhibitors Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Leukotriene Inhibitors Sales Market Share in Value by Application in 2022
Figure 44. Latin America Leukotriene Inhibitors Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Leukotriene Inhibitors Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Leukotriene Inhibitors Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Leukotriene Inhibitors Manufacturing Cost Structure
Figure 49. Leukotriene Inhibitors Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed